Professor Martin Schlumberger

Professor of Oncology at Paris-Saclay University, Martin Schlumberger served as head of the Department of Nuclear Medicine and Endocrine Oncology at Gustave Roussy, as well as Director of the School of Cancer Sciences and the Doctoral School of Oncology at Paris-Saclay University.

His main areas of interest are the use of radioactive isotopes in medicine and the management of tumors of the thyroid and endocrine glands. He has studied the mechanisms of tumorigenesis, the diagnostic and therapeutic management and follow-up of these patients, and the medico-economic evaluation of each of these phases. He participated in the assessment of health risks associated with medical exposure to iodine-131 and the Chernobyl accident, as well as in the organization of potassium iodide prophylaxis in France.

He has published more than 350 original articles in peer-reviewed English-language journals, 80 review articles, 60 book chapters, and two books. He has been invited to deliver more than 200 invited lectures at international conferences and has received several awards in France (including awards from the Academy of Medicine and the Academy of Sciences) and in the United States as a visiting professor at several institutions (Johns Hopkins, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Harvard Medical School). He has participated in European and American expert panels that have produced guidelines for the management of thyroid cancers, and in 2009 his department was designated “National Expert Center for Refractory Thyroid Cancers” as part of INCa’s “rare cancers” networks.

An associate professor at La Sapienza University of Rome, Martin Schlumberger is also a member of several learned societies, including the European Thyroid Association and the American Thyroid Association, and chairs the EORTC’s “Endocrine Tumors” group. He serves on the editorial boards of several English-language journals and chaired the International Thyroid Congress in Paris in September 2010.